Clinical
• • New approaches for protecting research participants, particularly patient privacy and confidentiality of their data • • New tools for building, analyzing, and sharing large sets of data • • Improved FDA oversight of tests, drugs, and other technologies to support innovation while ensuring these products are safe and effective. • • New partnerships of scientists in a wide range of specialties, as well as people from the patient advocacy community, universities, pharmaceutical companies, and others. Nursing science fits well with this initiative. Nursing has always focused on human responses to health and illness, which is well within the realm of precision medicine. The National Institute of Nursing Research (NINR) is supporting this Precision Medicine Initiative with a focus on symptom science (NINR, 2015) . NINR supports interprofessional research that integrates the biological and behavioral sciences with patient outcomes rather than specific disease outcomes (NINR, n.d.). NINR through an emphasis on symptom science supports nursing scientists with interprofessional teams who are contributing research findings that can predict individual's most at-risk for adverse symptoms and conditions, monitor treatment efficacy, and guide interventions to improve health and symptom outcomes (NINR, 2015) .
Nurse experts in ethics, informatics, bench research, big data, and clinical research all fit within the opportunities and challenges of this new Precision Medicine Initiative. The synergy created by interprofessional research teams is well engrained in nursing research and NINR. Nursing research has a large role to play in the Precision Medicine Initiative. For example, NINR's intramural research program developed the National Institute of Health (NIH) symptom science model.
The NIH NINR intramural research program developed the National Institutes of Health Symptom Science Model to guide research (Cashion & Grady, 2015) . Nurse researchers can use this model to guide biobehavioral research to address complex symptoms and develop targeted interventions. This model is also used as a training framework and career development to enhance patient outcomes including health related quality of life (Cashion & Grady, 2015) . This model guides scientists through the process of identifying symptoms clusters, standardizing how syndromes are measured across groups or conditions, and identifying biomarkers associated with symptoms and symptoms experiences and finally developing treatments and interventions that prevent or reduce symptoms (NINR, 2015) . This aligns very well with precision medicine and should be integrated into nursing research proposals as appropriate.
Nursing science can greatly benefit by this latest Precision Medicine Initiative by identifying their strengths and partnering with interprofessional colleagues to build a research team that can take full advantage of the emerging human data sets available that will include extensive characterization of biological specimens, behavioral data all linked to their electronic health records (Collins & Varmus, 2015) .
For more information about the Precision Medicine Initiative, please see The NIH white paper titled "The Precision Medicine Initiative Cohort Program-Building a Research Foundation for the 21st Century Medicine." It can be accessed at https://www.nih.gov/precision-medicine-initiativecohort-program. For more information about Precision Medicine in cancer research, please visit the National Cancer Institute's web site, http://www. cancer.gov/research/key-initiatives/precision-medicine.
